Global Targeted Therapy Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Targeted Therapy Drugs market size was valued at US$ 161681 million in 2025 and is forecast to a readjusted size of US$ 231501 million by 2032 with a CAGR of 5.4% during review period.
In 2025, global Targeted Therapy Drugs reached approximately 73.33 M Units, with an average global market price of around 2143 USD per Unit.
Targeted therapy drugs are medicines designed to specifically act on defined molecular targets—such as genes, proteins, receptors, or signaling pathways—that play a key role in the development or progression of a disease. Unlike traditional therapies that act broadly on rapidly dividing cells or whole organ systems, targeted therapies aim to interfere precisely with disease-driving mechanisms, thereby improving therapeutic effectiveness while reducing unintended damage to healthy cells.Targeted therapies are widely used in oncology, where they block cancer-specific mutations, growth signals, or angiogenesis pathways, but they are also increasingly important in autoimmune diseases, inflammatory disorders, and rare genetic conditions. These drugs may take the form of small molecules (often taken orally and acting inside cells) or biologics such as monoclonal antibodies (typically acting on extracellular or cell-surface targets). Their development relies heavily on advances in molecular biology, genomics, and biomarker identification.
Targeted therapy drugs address some of the most persistent pain points in modern medicine by moving beyond broad, non-specific treatment approaches toward therapies that act on clearly defined molecular drivers of disease, enabling better efficacy with a more manageable safety profile and greater consistency in patient response. By aligning treatment with genetic mutations, signaling pathways, or disease-specific receptors, these drugs help reduce unnecessary toxicity, avoid overtreatment, and improve outcomes in conditions where traditional therapies often fall short or show high variability. The expansion of genomic testing, biomarker discovery, and molecular diagnostics has accelerated the adoption of targeted therapies, while rising prevalence of cancer, autoimmune disorders, and rare diseases continues to fuel demand for more precise and durable treatment options. Looking ahead, the market potential for targeted therapy drugs remains strong as pipelines deepen across oncology and non-oncology indications, combination strategies improve resistance management, and healthcare systems increasingly recognize the long-term value of therapies that deliver predictable, mechanism-based benefits, positioning targeted therapies as a cornerstone of future drug development and precision medicine.
The upstream raw materials for Targeted Therapy Drugs mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca, among others. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
This report is a detailed and comprehensive analysis for global Targeted Therapy Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Therapy Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Therapy Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Targeted Therapy Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Therapy Drugs, with price, sales quantity, revenue, and global market share of Targeted Therapy Drugs from 2021 to 2026.
Chapter 3, the Targeted Therapy Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Therapy Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Targeted Therapy Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Therapy Drugs.
Chapter 14 and 15, to describe Targeted Therapy Drugs sales channel, distributors, customers, research findings and conclusion.
In 2025, global Targeted Therapy Drugs reached approximately 73.33 M Units, with an average global market price of around 2143 USD per Unit.
Targeted therapy drugs are medicines designed to specifically act on defined molecular targets—such as genes, proteins, receptors, or signaling pathways—that play a key role in the development or progression of a disease. Unlike traditional therapies that act broadly on rapidly dividing cells or whole organ systems, targeted therapies aim to interfere precisely with disease-driving mechanisms, thereby improving therapeutic effectiveness while reducing unintended damage to healthy cells.Targeted therapies are widely used in oncology, where they block cancer-specific mutations, growth signals, or angiogenesis pathways, but they are also increasingly important in autoimmune diseases, inflammatory disorders, and rare genetic conditions. These drugs may take the form of small molecules (often taken orally and acting inside cells) or biologics such as monoclonal antibodies (typically acting on extracellular or cell-surface targets). Their development relies heavily on advances in molecular biology, genomics, and biomarker identification.
Targeted therapy drugs address some of the most persistent pain points in modern medicine by moving beyond broad, non-specific treatment approaches toward therapies that act on clearly defined molecular drivers of disease, enabling better efficacy with a more manageable safety profile and greater consistency in patient response. By aligning treatment with genetic mutations, signaling pathways, or disease-specific receptors, these drugs help reduce unnecessary toxicity, avoid overtreatment, and improve outcomes in conditions where traditional therapies often fall short or show high variability. The expansion of genomic testing, biomarker discovery, and molecular diagnostics has accelerated the adoption of targeted therapies, while rising prevalence of cancer, autoimmune disorders, and rare diseases continues to fuel demand for more precise and durable treatment options. Looking ahead, the market potential for targeted therapy drugs remains strong as pipelines deepen across oncology and non-oncology indications, combination strategies improve resistance management, and healthcare systems increasingly recognize the long-term value of therapies that deliver predictable, mechanism-based benefits, positioning targeted therapies as a cornerstone of future drug development and precision medicine.
The upstream raw materials for Targeted Therapy Drugs mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca, among others. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
This report is a detailed and comprehensive analysis for global Targeted Therapy Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Therapy Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Therapy Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Targeted Therapy Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Kinase Inhibitors
- ADC
- Others
- Oral Drugs
- Injectable Drugs
- Others
- Small Molecule Drugs
- Antibody Drugs
- Others
- Cancer
- Rare Diseases
- Others
- Roche
- Novartis
- Merck
- Pfizer
- AstraZeneca
- Johnson & Johnson
- Bristol Myers Squibb
- Bayer
- GSK
- Daiichi Sankyo
- Amgen
- Eli Lilly and Company
- AbbVie
- Sanofi
- Takeda
- Boehringer Ingelheim
- Beigene, Ltd.
- Jiangsu Hengrui Medicine
- INNOVENT BIOLOGICS(SUZHOU)
- Betta Pharmaceuticals
- Remegen Co.,Ltd.
- Shanghai Allist Pharmaceuticals
- Innocare
- Huiyu Pharmaceuticals
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Therapy Drugs, with price, sales quantity, revenue, and global market share of Targeted Therapy Drugs from 2021 to 2026.
Chapter 3, the Targeted Therapy Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Therapy Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Targeted Therapy Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Therapy Drugs.
Chapter 14 and 15, to describe Targeted Therapy Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Therapy Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Kinase Inhibitors
1.3.3 ADC
1.3.4 Others
1.4 Market Analysis by Administration Route
1.4.1 Overview: Global Targeted Therapy Drugs Consumption Value by Administration Route: 2021 Versus 2025 Versus 2032
1.4.2 Oral Drugs
1.4.3 Injectable Drugs
1.4.4 Others
1.5 Market Analysis by Molecular Properties
1.5.1 Overview: Global Targeted Therapy Drugs Consumption Value by Molecular Properties: 2021 Versus 2025 Versus 2032
1.5.2 Small Molecule Drugs
1.5.3 Antibody Drugs
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Targeted Therapy Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Cancer
1.6.3 Rare Diseases
1.6.4 Others
1.7 Global Targeted Therapy Drugs Market Size & Forecast
1.7.1 Global Targeted Therapy Drugs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Targeted Therapy Drugs Sales Quantity (2021-2032)
1.7.3 Global Targeted Therapy Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Targeted Therapy Drugs Product and Services
2.1.4 Roche Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Targeted Therapy Drugs Product and Services
2.2.4 Novartis Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Targeted Therapy Drugs Product and Services
2.3.4 Merck Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Targeted Therapy Drugs Product and Services
2.4.4 Pfizer Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Targeted Therapy Drugs Product and Services
2.5.4 AstraZeneca Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Targeted Therapy Drugs Product and Services
2.6.4 Johnson & Johnson Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Bristol Myers Squibb
2.7.1 Bristol Myers Squibb Details
2.7.2 Bristol Myers Squibb Major Business
2.7.3 Bristol Myers Squibb Targeted Therapy Drugs Product and Services
2.7.4 Bristol Myers Squibb Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bristol Myers Squibb Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Targeted Therapy Drugs Product and Services
2.8.4 Bayer Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bayer Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Targeted Therapy Drugs Product and Services
2.9.4 GSK Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GSK Recent Developments/Updates
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business
2.10.3 Daiichi Sankyo Targeted Therapy Drugs Product and Services
2.10.4 Daiichi Sankyo Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Daiichi Sankyo Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Targeted Therapy Drugs Product and Services
2.11.4 Amgen Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Amgen Recent Developments/Updates
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Targeted Therapy Drugs Product and Services
2.12.4 Eli Lilly and Company Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Eli Lilly and Company Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Targeted Therapy Drugs Product and Services
2.13.4 AbbVie Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AbbVie Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Targeted Therapy Drugs Product and Services
2.14.4 Sanofi Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sanofi Recent Developments/Updates
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Targeted Therapy Drugs Product and Services
2.15.4 Takeda Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Takeda Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim Targeted Therapy Drugs Product and Services
2.16.4 Boehringer Ingelheim Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Beigene, Ltd.
2.17.1 Beigene, Ltd. Details
2.17.2 Beigene, Ltd. Major Business
2.17.3 Beigene, Ltd. Targeted Therapy Drugs Product and Services
2.17.4 Beigene, Ltd. Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beigene, Ltd. Recent Developments/Updates
2.18 Jiangsu Hengrui Medicine
2.18.1 Jiangsu Hengrui Medicine Details
2.18.2 Jiangsu Hengrui Medicine Major Business
2.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs Product and Services
2.18.4 Jiangsu Hengrui Medicine Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.19 INNOVENT BIOLOGICS(SUZHOU)
2.19.1 INNOVENT BIOLOGICS(SUZHOU) Details
2.19.2 INNOVENT BIOLOGICS(SUZHOU) Major Business
2.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Product and Services
2.19.4 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
2.20 Betta Pharmaceuticals
2.20.1 Betta Pharmaceuticals Details
2.20.2 Betta Pharmaceuticals Major Business
2.20.3 Betta Pharmaceuticals Targeted Therapy Drugs Product and Services
2.20.4 Betta Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Betta Pharmaceuticals Recent Developments/Updates
2.21 Remegen Co.,Ltd.
2.21.1 Remegen Co.,Ltd. Details
2.21.2 Remegen Co.,Ltd. Major Business
2.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs Product and Services
2.21.4 Remegen Co.,Ltd. Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Remegen Co.,Ltd. Recent Developments/Updates
2.22 Shanghai Allist Pharmaceuticals
2.22.1 Shanghai Allist Pharmaceuticals Details
2.22.2 Shanghai Allist Pharmaceuticals Major Business
2.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Product and Services
2.22.4 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.23 Innocare
2.23.1 Innocare Details
2.23.2 Innocare Major Business
2.23.3 Innocare Targeted Therapy Drugs Product and Services
2.23.4 Innocare Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Innocare Recent Developments/Updates
2.24 Huiyu Pharmaceuticals
2.24.1 Huiyu Pharmaceuticals Details
2.24.2 Huiyu Pharmaceuticals Major Business
2.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs Product and Services
2.24.4 Huiyu Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Huiyu Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED THERAPY DRUGS BY MANUFACTURER
3.1 Global Targeted Therapy Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Targeted Therapy Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Targeted Therapy Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Targeted Therapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Targeted Therapy Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Targeted Therapy Drugs Manufacturer Market Share in 2025
3.5 Targeted Therapy Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeted Therapy Drugs Market: Region Footprint
3.5.2 Targeted Therapy Drugs Market: Company Product Type Footprint
3.5.3 Targeted Therapy Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Therapy Drugs Market Size by Region
4.1.1 Global Targeted Therapy Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Targeted Therapy Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Targeted Therapy Drugs Average Price by Region (2021-2032)
4.2 North America Targeted Therapy Drugs Consumption Value (2021-2032)
4.3 Europe Targeted Therapy Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Targeted Therapy Drugs Consumption Value (2021-2032)
4.5 South America Targeted Therapy Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Targeted Therapy Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
5.2 Global Targeted Therapy Drugs Consumption Value by Type (2021-2032)
5.3 Global Targeted Therapy Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
6.2 Global Targeted Therapy Drugs Consumption Value by Application (2021-2032)
6.3 Global Targeted Therapy Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
7.2 North America Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
7.3 North America Targeted Therapy Drugs Market Size by Country
7.3.1 North America Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Targeted Therapy Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Targeted Therapy Drugs Market Size by Country
8.3.1 Europe Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Targeted Therapy Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Targeted Therapy Drugs Market Size by Region
9.3.1 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
10.2 South America Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
10.3 South America Targeted Therapy Drugs Market Size by Country
10.3.1 South America Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Targeted Therapy Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Targeted Therapy Drugs Market Size by Country
11.3.1 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Targeted Therapy Drugs Market Drivers
12.2 Targeted Therapy Drugs Market Restraints
12.3 Targeted Therapy Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Therapy Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Therapy Drugs
13.3 Targeted Therapy Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Therapy Drugs Typical Distributors
14.3 Targeted Therapy Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Therapy Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Kinase Inhibitors
1.3.3 ADC
1.3.4 Others
1.4 Market Analysis by Administration Route
1.4.1 Overview: Global Targeted Therapy Drugs Consumption Value by Administration Route: 2021 Versus 2025 Versus 2032
1.4.2 Oral Drugs
1.4.3 Injectable Drugs
1.4.4 Others
1.5 Market Analysis by Molecular Properties
1.5.1 Overview: Global Targeted Therapy Drugs Consumption Value by Molecular Properties: 2021 Versus 2025 Versus 2032
1.5.2 Small Molecule Drugs
1.5.3 Antibody Drugs
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Targeted Therapy Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Cancer
1.6.3 Rare Diseases
1.6.4 Others
1.7 Global Targeted Therapy Drugs Market Size & Forecast
1.7.1 Global Targeted Therapy Drugs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Targeted Therapy Drugs Sales Quantity (2021-2032)
1.7.3 Global Targeted Therapy Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Targeted Therapy Drugs Product and Services
2.1.4 Roche Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Targeted Therapy Drugs Product and Services
2.2.4 Novartis Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Targeted Therapy Drugs Product and Services
2.3.4 Merck Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Targeted Therapy Drugs Product and Services
2.4.4 Pfizer Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Targeted Therapy Drugs Product and Services
2.5.4 AstraZeneca Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Targeted Therapy Drugs Product and Services
2.6.4 Johnson & Johnson Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Bristol Myers Squibb
2.7.1 Bristol Myers Squibb Details
2.7.2 Bristol Myers Squibb Major Business
2.7.3 Bristol Myers Squibb Targeted Therapy Drugs Product and Services
2.7.4 Bristol Myers Squibb Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bristol Myers Squibb Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Targeted Therapy Drugs Product and Services
2.8.4 Bayer Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bayer Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Targeted Therapy Drugs Product and Services
2.9.4 GSK Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GSK Recent Developments/Updates
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business
2.10.3 Daiichi Sankyo Targeted Therapy Drugs Product and Services
2.10.4 Daiichi Sankyo Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Daiichi Sankyo Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Targeted Therapy Drugs Product and Services
2.11.4 Amgen Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Amgen Recent Developments/Updates
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Targeted Therapy Drugs Product and Services
2.12.4 Eli Lilly and Company Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Eli Lilly and Company Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Targeted Therapy Drugs Product and Services
2.13.4 AbbVie Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AbbVie Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Targeted Therapy Drugs Product and Services
2.14.4 Sanofi Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sanofi Recent Developments/Updates
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Targeted Therapy Drugs Product and Services
2.15.4 Takeda Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Takeda Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim Targeted Therapy Drugs Product and Services
2.16.4 Boehringer Ingelheim Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Beigene, Ltd.
2.17.1 Beigene, Ltd. Details
2.17.2 Beigene, Ltd. Major Business
2.17.3 Beigene, Ltd. Targeted Therapy Drugs Product and Services
2.17.4 Beigene, Ltd. Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beigene, Ltd. Recent Developments/Updates
2.18 Jiangsu Hengrui Medicine
2.18.1 Jiangsu Hengrui Medicine Details
2.18.2 Jiangsu Hengrui Medicine Major Business
2.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs Product and Services
2.18.4 Jiangsu Hengrui Medicine Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.19 INNOVENT BIOLOGICS(SUZHOU)
2.19.1 INNOVENT BIOLOGICS(SUZHOU) Details
2.19.2 INNOVENT BIOLOGICS(SUZHOU) Major Business
2.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Product and Services
2.19.4 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
2.20 Betta Pharmaceuticals
2.20.1 Betta Pharmaceuticals Details
2.20.2 Betta Pharmaceuticals Major Business
2.20.3 Betta Pharmaceuticals Targeted Therapy Drugs Product and Services
2.20.4 Betta Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Betta Pharmaceuticals Recent Developments/Updates
2.21 Remegen Co.,Ltd.
2.21.1 Remegen Co.,Ltd. Details
2.21.2 Remegen Co.,Ltd. Major Business
2.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs Product and Services
2.21.4 Remegen Co.,Ltd. Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Remegen Co.,Ltd. Recent Developments/Updates
2.22 Shanghai Allist Pharmaceuticals
2.22.1 Shanghai Allist Pharmaceuticals Details
2.22.2 Shanghai Allist Pharmaceuticals Major Business
2.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Product and Services
2.22.4 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.23 Innocare
2.23.1 Innocare Details
2.23.2 Innocare Major Business
2.23.3 Innocare Targeted Therapy Drugs Product and Services
2.23.4 Innocare Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Innocare Recent Developments/Updates
2.24 Huiyu Pharmaceuticals
2.24.1 Huiyu Pharmaceuticals Details
2.24.2 Huiyu Pharmaceuticals Major Business
2.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs Product and Services
2.24.4 Huiyu Pharmaceuticals Targeted Therapy Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Huiyu Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED THERAPY DRUGS BY MANUFACTURER
3.1 Global Targeted Therapy Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Targeted Therapy Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Targeted Therapy Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Targeted Therapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Targeted Therapy Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Targeted Therapy Drugs Manufacturer Market Share in 2025
3.5 Targeted Therapy Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeted Therapy Drugs Market: Region Footprint
3.5.2 Targeted Therapy Drugs Market: Company Product Type Footprint
3.5.3 Targeted Therapy Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Therapy Drugs Market Size by Region
4.1.1 Global Targeted Therapy Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Targeted Therapy Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Targeted Therapy Drugs Average Price by Region (2021-2032)
4.2 North America Targeted Therapy Drugs Consumption Value (2021-2032)
4.3 Europe Targeted Therapy Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Targeted Therapy Drugs Consumption Value (2021-2032)
4.5 South America Targeted Therapy Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Targeted Therapy Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
5.2 Global Targeted Therapy Drugs Consumption Value by Type (2021-2032)
5.3 Global Targeted Therapy Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
6.2 Global Targeted Therapy Drugs Consumption Value by Application (2021-2032)
6.3 Global Targeted Therapy Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
7.2 North America Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
7.3 North America Targeted Therapy Drugs Market Size by Country
7.3.1 North America Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Targeted Therapy Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Targeted Therapy Drugs Market Size by Country
8.3.1 Europe Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Targeted Therapy Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Targeted Therapy Drugs Market Size by Region
9.3.1 Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
10.2 South America Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
10.3 South America Targeted Therapy Drugs Market Size by Country
10.3.1 South America Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Targeted Therapy Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Targeted Therapy Drugs Market Size by Country
11.3.1 Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Targeted Therapy Drugs Market Drivers
12.2 Targeted Therapy Drugs Market Restraints
12.3 Targeted Therapy Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Therapy Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Therapy Drugs
13.3 Targeted Therapy Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Therapy Drugs Typical Distributors
14.3 Targeted Therapy Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Targeted Therapy Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Targeted Therapy Drugs Consumption Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 3. Global Targeted Therapy Drugs Consumption Value by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Targeted Therapy Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Targeted Therapy Drugs Product and Services
Table 8. Roche Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Targeted Therapy Drugs Product and Services
Table 13. Novartis Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Targeted Therapy Drugs Product and Services
Table 18. Merck Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Merck Recent Developments/Updates
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Targeted Therapy Drugs Product and Services
Table 23. Pfizer Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Pfizer Recent Developments/Updates
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Targeted Therapy Drugs Product and Services
Table 28. AstraZeneca Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. AstraZeneca Recent Developments/Updates
Table 30. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Targeted Therapy Drugs Product and Services
Table 33. Johnson & Johnson Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Johnson & Johnson Recent Developments/Updates
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb Major Business
Table 37. Bristol Myers Squibb Targeted Therapy Drugs Product and Services
Table 38. Bristol Myers Squibb Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Bristol Myers Squibb Recent Developments/Updates
Table 40. Bayer Basic Information, Manufacturing Base and Competitors
Table 41. Bayer Major Business
Table 42. Bayer Targeted Therapy Drugs Product and Services
Table 43. Bayer Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bayer Recent Developments/Updates
Table 45. GSK Basic Information, Manufacturing Base and Competitors
Table 46. GSK Major Business
Table 47. GSK Targeted Therapy Drugs Product and Services
Table 48. GSK Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GSK Recent Developments/Updates
Table 50. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 51. Daiichi Sankyo Major Business
Table 52. Daiichi Sankyo Targeted Therapy Drugs Product and Services
Table 53. Daiichi Sankyo Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Daiichi Sankyo Recent Developments/Updates
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Targeted Therapy Drugs Product and Services
Table 58. Amgen Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Amgen Recent Developments/Updates
Table 60. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 61. Eli Lilly and Company Major Business
Table 62. Eli Lilly and Company Targeted Therapy Drugs Product and Services
Table 63. Eli Lilly and Company Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Eli Lilly and Company Recent Developments/Updates
Table 65. AbbVie Basic Information, Manufacturing Base and Competitors
Table 66. AbbVie Major Business
Table 67. AbbVie Targeted Therapy Drugs Product and Services
Table 68. AbbVie Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. AbbVie Recent Developments/Updates
Table 70. Sanofi Basic Information, Manufacturing Base and Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Targeted Therapy Drugs Product and Services
Table 73. Sanofi Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sanofi Recent Developments/Updates
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Targeted Therapy Drugs Product and Services
Table 78. Takeda Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Major Business
Table 82. Boehringer Ingelheim Targeted Therapy Drugs Product and Services
Table 83. Boehringer Ingelheim Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Beigene, Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Beigene, Ltd. Major Business
Table 87. Beigene, Ltd. Targeted Therapy Drugs Product and Services
Table 88. Beigene, Ltd. Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Beigene, Ltd. Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 91. Jiangsu Hengrui Medicine Major Business
Table 92. Jiangsu Hengrui Medicine Targeted Therapy Drugs Product and Services
Table 93. Jiangsu Hengrui Medicine Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Manufacturing Base and Competitors
Table 96. INNOVENT BIOLOGICS(SUZHOU) Major Business
Table 97. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Product and Services
Table 98. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
Table 100. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 101. Betta Pharmaceuticals Major Business
Table 102. Betta Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 103. Betta Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Remegen Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 106. Remegen Co.,Ltd. Major Business
Table 107. Remegen Co.,Ltd. Targeted Therapy Drugs Product and Services
Table 108. Remegen Co.,Ltd. Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Remegen Co.,Ltd. Recent Developments/Updates
Table 110. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 111. Shanghai Allist Pharmaceuticals Major Business
Table 112. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 113. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 115. Innocare Basic Information, Manufacturing Base and Competitors
Table 116. Innocare Major Business
Table 117. Innocare Targeted Therapy Drugs Product and Services
Table 118. Innocare Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Innocare Recent Developments/Updates
Table 120. Huiyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 121. Huiyu Pharmaceuticals Major Business
Table 122. Huiyu Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 123. Huiyu Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Huiyu Pharmaceuticals Recent Developments/Updates
Table 125. Global Targeted Therapy Drugs Sales Quantity by Manufacturer (2021-2026) & (M Units)
Table 126. Global Targeted Therapy Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 127. Global Targeted Therapy Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 128. Market Position of Manufacturers in Targeted Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 129. Head Office and Targeted Therapy Drugs Production Site of Key Manufacturer
Table 130. Targeted Therapy Drugs Market: Company Product Type Footprint
Table 131. Targeted Therapy Drugs Market: Company Product Application Footprint
Table 132. Targeted Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 133. Targeted Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Targeted Therapy Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 135. Global Targeted Therapy Drugs Sales Quantity by Region (2021-2026) & (M Units)
Table 136. Global Targeted Therapy Drugs Sales Quantity by Region (2027-2032) & (M Units)
Table 137. Global Targeted Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Global Targeted Therapy Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 139. Global Targeted Therapy Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 140. Global Targeted Therapy Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 141. Global Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 142. Global Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 143. Global Targeted Therapy Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 144. Global Targeted Therapy Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 145. Global Targeted Therapy Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Targeted Therapy Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 148. Global Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 149. Global Targeted Therapy Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 150. Global Targeted Therapy Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 151. Global Targeted Therapy Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 152. Global Targeted Therapy Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 153. North America Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 154. North America Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 155. North America Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 156. North America Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 157. North America Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 158. North America Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 159. North America Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 162. Europe Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 163. Europe Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 164. Europe Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 165. Europe Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 166. Europe Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 167. Europe Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 168. Europe Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 170. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 171. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 172. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 173. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2021-2026) & (M Units)
Table 174. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2027-2032) & (M Units)
Table 175. Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 178. South America Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 179. South America Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 180. South America Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 181. South America Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 182. South America Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 183. South America Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 184. South America Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 186. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 187. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 188. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 189. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 190. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 191. Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 192. Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 193. Targeted Therapy Drugs Raw Material
Table 194. Key Manufacturers of Targeted Therapy Drugs Raw Materials
Table 195. Targeted Therapy Drugs Typical Distributors
Table 196. Targeted Therapy Drugs Typical Customers
Table 1. Global Targeted Therapy Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Targeted Therapy Drugs Consumption Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 3. Global Targeted Therapy Drugs Consumption Value by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Targeted Therapy Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Targeted Therapy Drugs Product and Services
Table 8. Roche Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Targeted Therapy Drugs Product and Services
Table 13. Novartis Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Targeted Therapy Drugs Product and Services
Table 18. Merck Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Merck Recent Developments/Updates
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Targeted Therapy Drugs Product and Services
Table 23. Pfizer Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Pfizer Recent Developments/Updates
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Targeted Therapy Drugs Product and Services
Table 28. AstraZeneca Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. AstraZeneca Recent Developments/Updates
Table 30. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Targeted Therapy Drugs Product and Services
Table 33. Johnson & Johnson Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Johnson & Johnson Recent Developments/Updates
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb Major Business
Table 37. Bristol Myers Squibb Targeted Therapy Drugs Product and Services
Table 38. Bristol Myers Squibb Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Bristol Myers Squibb Recent Developments/Updates
Table 40. Bayer Basic Information, Manufacturing Base and Competitors
Table 41. Bayer Major Business
Table 42. Bayer Targeted Therapy Drugs Product and Services
Table 43. Bayer Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bayer Recent Developments/Updates
Table 45. GSK Basic Information, Manufacturing Base and Competitors
Table 46. GSK Major Business
Table 47. GSK Targeted Therapy Drugs Product and Services
Table 48. GSK Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GSK Recent Developments/Updates
Table 50. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 51. Daiichi Sankyo Major Business
Table 52. Daiichi Sankyo Targeted Therapy Drugs Product and Services
Table 53. Daiichi Sankyo Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Daiichi Sankyo Recent Developments/Updates
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Targeted Therapy Drugs Product and Services
Table 58. Amgen Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Amgen Recent Developments/Updates
Table 60. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 61. Eli Lilly and Company Major Business
Table 62. Eli Lilly and Company Targeted Therapy Drugs Product and Services
Table 63. Eli Lilly and Company Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Eli Lilly and Company Recent Developments/Updates
Table 65. AbbVie Basic Information, Manufacturing Base and Competitors
Table 66. AbbVie Major Business
Table 67. AbbVie Targeted Therapy Drugs Product and Services
Table 68. AbbVie Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. AbbVie Recent Developments/Updates
Table 70. Sanofi Basic Information, Manufacturing Base and Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Targeted Therapy Drugs Product and Services
Table 73. Sanofi Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sanofi Recent Developments/Updates
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Targeted Therapy Drugs Product and Services
Table 78. Takeda Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Major Business
Table 82. Boehringer Ingelheim Targeted Therapy Drugs Product and Services
Table 83. Boehringer Ingelheim Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Beigene, Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Beigene, Ltd. Major Business
Table 87. Beigene, Ltd. Targeted Therapy Drugs Product and Services
Table 88. Beigene, Ltd. Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Beigene, Ltd. Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 91. Jiangsu Hengrui Medicine Major Business
Table 92. Jiangsu Hengrui Medicine Targeted Therapy Drugs Product and Services
Table 93. Jiangsu Hengrui Medicine Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Manufacturing Base and Competitors
Table 96. INNOVENT BIOLOGICS(SUZHOU) Major Business
Table 97. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Product and Services
Table 98. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
Table 100. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 101. Betta Pharmaceuticals Major Business
Table 102. Betta Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 103. Betta Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Remegen Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 106. Remegen Co.,Ltd. Major Business
Table 107. Remegen Co.,Ltd. Targeted Therapy Drugs Product and Services
Table 108. Remegen Co.,Ltd. Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Remegen Co.,Ltd. Recent Developments/Updates
Table 110. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 111. Shanghai Allist Pharmaceuticals Major Business
Table 112. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 113. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 115. Innocare Basic Information, Manufacturing Base and Competitors
Table 116. Innocare Major Business
Table 117. Innocare Targeted Therapy Drugs Product and Services
Table 118. Innocare Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Innocare Recent Developments/Updates
Table 120. Huiyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 121. Huiyu Pharmaceuticals Major Business
Table 122. Huiyu Pharmaceuticals Targeted Therapy Drugs Product and Services
Table 123. Huiyu Pharmaceuticals Targeted Therapy Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Huiyu Pharmaceuticals Recent Developments/Updates
Table 125. Global Targeted Therapy Drugs Sales Quantity by Manufacturer (2021-2026) & (M Units)
Table 126. Global Targeted Therapy Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 127. Global Targeted Therapy Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 128. Market Position of Manufacturers in Targeted Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 129. Head Office and Targeted Therapy Drugs Production Site of Key Manufacturer
Table 130. Targeted Therapy Drugs Market: Company Product Type Footprint
Table 131. Targeted Therapy Drugs Market: Company Product Application Footprint
Table 132. Targeted Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 133. Targeted Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Targeted Therapy Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 135. Global Targeted Therapy Drugs Sales Quantity by Region (2021-2026) & (M Units)
Table 136. Global Targeted Therapy Drugs Sales Quantity by Region (2027-2032) & (M Units)
Table 137. Global Targeted Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Global Targeted Therapy Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 139. Global Targeted Therapy Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 140. Global Targeted Therapy Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 141. Global Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 142. Global Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 143. Global Targeted Therapy Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 144. Global Targeted Therapy Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 145. Global Targeted Therapy Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Targeted Therapy Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 148. Global Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 149. Global Targeted Therapy Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 150. Global Targeted Therapy Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 151. Global Targeted Therapy Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 152. Global Targeted Therapy Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 153. North America Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 154. North America Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 155. North America Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 156. North America Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 157. North America Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 158. North America Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 159. North America Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 162. Europe Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 163. Europe Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 164. Europe Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 165. Europe Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 166. Europe Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 167. Europe Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 168. Europe Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 170. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 171. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 172. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 173. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2021-2026) & (M Units)
Table 174. Asia-Pacific Targeted Therapy Drugs Sales Quantity by Region (2027-2032) & (M Units)
Table 175. Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Targeted Therapy Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 178. South America Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 179. South America Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 180. South America Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 181. South America Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 182. South America Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 183. South America Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 184. South America Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2021-2026) & (M Units)
Table 186. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Type (2027-2032) & (M Units)
Table 187. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2021-2026) & (M Units)
Table 188. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Application (2027-2032) & (M Units)
Table 189. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2021-2026) & (M Units)
Table 190. Middle East & Africa Targeted Therapy Drugs Sales Quantity by Country (2027-2032) & (M Units)
Table 191. Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 192. Middle East & Africa Targeted Therapy Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 193. Targeted Therapy Drugs Raw Material
Table 194. Key Manufacturers of Targeted Therapy Drugs Raw Materials
Table 195. Targeted Therapy Drugs Typical Distributors
Table 196. Targeted Therapy Drugs Typical Customers
LIST OF FIGURES
Figure 1. Targeted Therapy Drugs Picture
Figure 2. Global Targeted Therapy Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Targeted Therapy Drugs Revenue Market Share by Type in 2025
Figure 4. Kinase Inhibitors Examples
Figure 5. ADC Examples
Figure 6. Others Examples
Figure 7. Global Targeted Therapy Drugs Revenue by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Targeted Therapy Drugs Revenue Market Share by Administration Route in 2025
Figure 9. Oral Drugs Examples
Figure 10. Injectable Drugs Examples
Figure 11. Others Examples
Figure 12. Global Targeted Therapy Drugs Revenue by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Targeted Therapy Drugs Revenue Market Share by Molecular Properties in 2025
Figure 14. Small Molecule Drugs Examples
Figure 15. Antibody Drugs Examples
Figure 16. Others Examples
Figure 17. Global Targeted Therapy Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Targeted Therapy Drugs Revenue Market Share by Application in 2025
Figure 19. Cancer Examples
Figure 20. Rare Diseases Examples
Figure 21. Others Examples
Figure 22. Global Targeted Therapy Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Targeted Therapy Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Targeted Therapy Drugs Sales Quantity (2021-2032) & (M Units)
Figure 25. Global Targeted Therapy Drugs Price (2021-2032) & (US$/Unit)
Figure 26. Global Targeted Therapy Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Targeted Therapy Drugs Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Targeted Therapy Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Targeted Therapy Drugs Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Targeted Therapy Drugs Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Targeted Therapy Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Targeted Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Targeted Therapy Drugs Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Targeted Therapy Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. Global Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Targeted Therapy Drugs Revenue Market Share by Application (2021-2032)
Figure 43. Global Targeted Therapy Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. France Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Targeted Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 64. China Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 67. India Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 84. Targeted Therapy Drugs Market Drivers
Figure 85. Targeted Therapy Drugs Market Restraints
Figure 86. Targeted Therapy Drugs Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs in 2025
Figure 89. Manufacturing Process Analysis of Targeted Therapy Drugs
Figure 90. Targeted Therapy Drugs Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. Targeted Therapy Drugs Picture
Figure 2. Global Targeted Therapy Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Targeted Therapy Drugs Revenue Market Share by Type in 2025
Figure 4. Kinase Inhibitors Examples
Figure 5. ADC Examples
Figure 6. Others Examples
Figure 7. Global Targeted Therapy Drugs Revenue by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Targeted Therapy Drugs Revenue Market Share by Administration Route in 2025
Figure 9. Oral Drugs Examples
Figure 10. Injectable Drugs Examples
Figure 11. Others Examples
Figure 12. Global Targeted Therapy Drugs Revenue by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Targeted Therapy Drugs Revenue Market Share by Molecular Properties in 2025
Figure 14. Small Molecule Drugs Examples
Figure 15. Antibody Drugs Examples
Figure 16. Others Examples
Figure 17. Global Targeted Therapy Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Targeted Therapy Drugs Revenue Market Share by Application in 2025
Figure 19. Cancer Examples
Figure 20. Rare Diseases Examples
Figure 21. Others Examples
Figure 22. Global Targeted Therapy Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Targeted Therapy Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Targeted Therapy Drugs Sales Quantity (2021-2032) & (M Units)
Figure 25. Global Targeted Therapy Drugs Price (2021-2032) & (US$/Unit)
Figure 26. Global Targeted Therapy Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Targeted Therapy Drugs Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Targeted Therapy Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Targeted Therapy Drugs Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Targeted Therapy Drugs Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Targeted Therapy Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Targeted Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Targeted Therapy Drugs Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Targeted Therapy Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. Global Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Targeted Therapy Drugs Revenue Market Share by Application (2021-2032)
Figure 43. Global Targeted Therapy Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. France Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Targeted Therapy Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Targeted Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 64. China Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 67. India Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Targeted Therapy Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Targeted Therapy Drugs Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Targeted Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 84. Targeted Therapy Drugs Market Drivers
Figure 85. Targeted Therapy Drugs Market Restraints
Figure 86. Targeted Therapy Drugs Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs in 2025
Figure 89. Manufacturing Process Analysis of Targeted Therapy Drugs
Figure 90. Targeted Therapy Drugs Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
